Tatva Chintan Pharma Chem, a specialty chemical manufacturing company, has filed preliminary papers with the market regulator Sebi for an initial public offering (IPO). The IPO will comprise a fresh issue of shares worth Rs 225 crore and an offer of sale amounting to Rs 225 crore by existing promoters and shareholders, according to the company’s draft red herring prospectus.
Tatva Chintan Pharma Chem will use the IPO proceeds to fund its capital expenditure requirements, expand the Dahej manufacturing facility and for general corporate purposes.
Based in Vadodara, Tatva Chintan exports its products to more than 25 countries, including the USA, China, Germany, Japan, South Africa and the UK.
ICICI Securities and JM Financials are the merchant bankers to the issue of Tatva Chintan Pharma.
more recommended stories
PIP: How much Britons can expect to receive from the DWP in 2021 payments | Personal Finance | Finance
They must have a physical or.
Petrol, Diesel Prices Kept Steady Across All Metros On Sunday
Petrol, Diesel Prices Today: Petrol and.
LinkedIn says user data scraped and put for sale: Report
BENGALURU: Personal data of about 500.
HMRC update: Britons urged to check their tax code – what the new 1257L code means | Personal Finance | Finance
Why should a tax code be.